← Leaderboards
Takuji Suzuki
Cincinnati Childrens Hosp Med Ctr
$1,560,000
Attributed
$1,560,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $390K · FY2017–20$500K$375K$250K$125K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$1,560,000 · 1
By mechanism
R01$1,560,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Nancy Ratner$25,011,276
- James Patrick Bridges$2,692,081
- Daniel Lucas$9,614,171
- Grant Sanford Schulert$3,706,690
- Paritha Arumugam$2,138,005
Others in their field
Other Emerging Leaders on “Alleles”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
- Paul John Norman · University Of Colorado Denver$12,197,519
- Badri N Vardarajan · University Of Miami School Of Medicine$11,890,673
- Jacqueline K White · Jackson Laboratory$11,525,170
- Jessica Brooke Langbaum · Banner Health$11,370,996
Research focus
AllelesAblationAlveolar MacrophagesAnimal ModelAutologousAlveolarBiological MarkersBone Marrow PurgingBone Marrow TransplantationCell ModelCellsCell TherapyCell TransplantationBaseCell TypeCessation Of LifeCharacteristicsChildCrispr/Cas TechnologyCsf2ra GeneCsf2rb GeneDisease PhenotypeEndonucleaseEngraftment
Grant awards (4)
Genome edited iPS cell-derived macrophages as a novel lung cell therapy$390,000
R01 · FY2020 · HL · contact PI
Genome edited iPS cell-derived macrophages as a novel lung cell therapy$390,000
R01 · FY2019 · HL · contact PI
Genome edited iPS cell-derived macrophages as a novel lung cell therapy$390,000
R01 · FY2018 · HL · contact PI
Genome edited iPS cell-derived macrophages as a novel lung cell therapy$390,000
R01 · FY2017 · HL · contact PI